Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report

Gallbladder cancer (GBC) is the most aggressive malignancy of the biliary tract with poor prognosis. Several targetable genetic alterations have been identified in GBC; however, responses to targeted therapy are disappointing. We report a case of a 58-year-old Chinese woman with GBC who was detected...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yuling, Lizaso, Analyn, Mao, Xinru, Yang, Nong, Zhang, Yongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575933/
https://www.ncbi.nlm.nih.gov/pubmed/33145318
http://dx.doi.org/10.21037/atm-20-1007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575933/
https://www.ncbi.nlm.nih.gov/pubmed/33145318
http://dx.doi.org/10.21037/atm-20-1007

Ejemplares similares